|Articles|September 1, 2002

Effective Lipid Management: A Managed Care Perspective of Clinical Findings
Volume 8
Issue 12 Suppl

Niacin-Based Therapy for Dyslipidemia: Past Evidence and Future Advances

Author(s)Matthew K. Ito, PharmD

Download PDF: Niacin-Based Therapy for Dyslipidemia: Past Evidence and Future Advances

Articles in this issue

over 23 years ago

Article

Participating Faculty

over 23 years ago

Article

Effective Lipid Management: A Managed Care Perspective of Clinical Findings

over 23 years ago

Article

New Therapeutic Options in the National Cholesterol Education Program Adult Treatment Panel III

over 23 years ago

Article

Understanding Niacin Formulations

over 23 years ago

Article

Delivering Effective Lipid Management in the Managed Care Setting

over 23 years ago

Article

Continuing Education Quiz

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

ByNate C. Apathy, PhD

January 27th 2026

Building Trust: Public Priorities for Health Care AI Labeling

ByMorgan L. Sielaff, BS,Jodyn Platt, PhD, MPH,Sean Tan, MPP,Kerry A. Ryan, MA,Paige Nong, PhD,Sharon L. R. Kardia, PhD

January 27th 2026

Ambient AI Tool Adoption in US Hospitals and Associated Factors

ByFreddie Yang, MA,Ilana Graetz, PhD

January 27th 2026

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Niacin-Based Therapy for Dyslipidemia: Past Evidence and Future Advances

Articles in this issue

Newsletter

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule

Experts Warn CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust

New Dermatologic Therapies Make Waves at Maui Derm 2026

Trulicity, Botox Headline Drugs Included in the Third Cycle of Medicare Price Negotiations

FDA Greenlights D-VRd Quadruplet for Newly Diagnosed Multiple Myeloma